Reglicem is an innovative nutraceutical product developed by Biofarma Group, able to reduce IFG and IGT values in patients with prediabetes conditions. 

• Curcuma longa is effective in reducing glycemia and hyperlipidaemia and improves insulin sensitivity
• Berberis vulgaris promotes glucose and HbA1c lowering in patients with diabetes type II
• Lagerstroemia speciosa exhibits hypoglycaemic, antihyperlipidemic and antioxidant activities. 
• Inositol is effective in decreasing the level of insulin resistance
• Chromium acts as an ‘insulin-sensitizing’ agent

This Techincal Paper is from Biofarma.